Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

3-Chloro-6-{4-[3-(4-chloro-phen-oxy)prop-yl]piperazin-1-yl}pyridazine.

ABSTRACT: In the title compound, C(17)H(20)Cl(2)N(4)O, the piperazine ring adopts a chair conformation and the dihedral angle between the pyridazine ring and the benzene ring is 36.3?(1)°. In the crystal, weak C-H?O and C-H?(N,N) inter-actions help to establish the packing, which also features short inter-molecular Cl?Cl contacts [3.331?(2)?Å].

SUBMITTER: Wang H

PROVIDER: S-EPMC2983611 | biostudies-literature | 2010 Feb

REPOSITORIES: biostudies-literature

ACCESS DATA

Json Xml

Publications

3-Chloro-6-{4-[3-(4-chloro-phen-oxy)prop-yl]piperazin-1-yl}pyridazine.

Wang Hongliang H Xiao Junhai J Zhang Xian X Sun Tiemin T Li Song S

Acta crystallographica. Section E, Structure reports online 20100227 Pt 3

In the title compound, C(17)H(20)Cl(2)N(4)O, the piperazine ring adopts a chair conformation and the dihedral angle between the pyridazine ring and the benzene ring is 36.3 (1)°. In the crystal, weak C-H⋯O and C-H⋯(N,N) inter-actions help to establish the packing, which also features short inter-molecular Cl⋯Cl contacts [3.331 (2) Å]. ...[more]

PMID: 21580453

Similar Datasets

3-Chloro-6-{4-[3-(trifluoro-meth-yl)phen-yl]piperazin-1-yl}pyridazine.

Project description:The title compound, C(15)H(14)ClF(3)N(4), was synthesized from 3,6-dichloro-pyridazine and 1-[3-(trifluoro-meth-yl)phen-yl]piper-azine. The piperazine ring is flanked by 3-chloro-pyridazine and 3-trifluoro-methyl-phenyl rings and adopts a chair conformation, whereas the 3-chloro-pyridazine and 3-trifluoro-methyl-phenyl rings are planar, with maximum deviations of 0.0069?(13) and 0.0133?(14)?Å, respectively. The crystal structure is stabilized by weak inter-molecular C-H?N hydrogen-bond inter-actions.

| S-EPMC2983628 | biostudies-literature

3-Chloro-6-[4-(2-pyrid-yl)piperazin-1-yl]pyridazine.

Project description:In the title compound, C(13)H(14)ClN(5), the piperazine ring adopts a chair conformation and the dihedral angle between the aromatic rings is 13.91?(7)°. The crystal structure is stabilized by weak inter-molecular C-H?N hydrogen-bond inter-actions.

| S-EPMC2980189 | biostudies-literature

1-[4-(3-Chloro-prop-oxy)-2-hydroxy-phen-yl]ethanone.

Project description:The title compound, C(11)H(13)ClO(3), has been obtained in the reaction of 2, 4-dihydroxy-lacetonephenone, potassium carbonate and 1-bromo-3-chloro-hexane. The hydr-oxy group is involved in an intra-molecular O-H?O hydrogen bond. The crystal packing exhibits no significantly short inter-molecular contacts.

| S-EPMC2980010 | biostudies-literature

Bis[5-chloro-2-(prop-2-yn-1-yl-oxy)phen-yl]methane.

Project description:The mol-ecule of the title compound, C(19)H(14)Cl(2)O(2), has two benzene rings connected to a methyl-ene C atom, and the rings are aligned at 66.3 (1)°. Inter-molecular C-H⋯π and π-π stacking inter-actions are observed in the crystal structure, the centroid-centroid distances between parallel benzene rings being 3.7529 (12) and 3.6201 (12) Å, respectively.

| S-EPMC3051580 | biostudies-literature

(E)-1-{4-[Bis(4-bromo-phen-yl)meth-yl]piperazin-1-yl}-3-(4-eth-oxy-3-meth-oxy-phen-yl)prop-2-en-1-one.

Project description:In the title mol-ecule, C(29)H(30)Br(2)N(2)O(3), the piperazine ring has a chair conformation and the C=C double bond has an E conformation. The dihedral angle between the bromo-benzene rings is 79.1?(3)°. In the crystal, mol-ecules are linked through C-H?O and C-H?Br hydrogen bonds.

| S-EPMC3254469 | biostudies-literature

(E)-1-{4-[Bis(4-meth-oxy-phen-yl)meth-yl]piperazin-1-yl}-3-(3,4-dieth-oxy-phen-yl)prop-2-en-1-one ethanol disolvate.

Project description:The asymmetric unit of the title compound, C(32)H(38)N(2)O(5)·2C(2)H(6)O, contains one main mol-ecule and two solvent mol-ecules, which inter-act via inter-molecular O-H⋯O hydrogen bonds. The piperazine ring adopts a chair conformation. The crystal packing exhibits weak inter-molecular C-H⋯O hydrogen bonds and voids of 31 Å(3).

| S-EPMC3274991 | biostudies-literature

(E)-3-(2-Eth-oxy-phen-yl)-1-{4-[(2-fluoro-phen-yl)(4-fluoro-phen-yl)meth-yl]piperazin-1-yl}prop-2-en-1-one.

Project description:In the title compound, C(28)H(28)F(2)N(2)O(2), the piperazine ring has a chair conformation with the pendant N-C bonds in equatorial orientations. The C=C double bond has an E conformation and the dihedral angle between the fluoro-benzene rings is 70.8?(3)°. In the crystal, mol-ecules are linked by C-H?O and C-H?F hydrogen bonds.

| S-EPMC3379522 | biostudies-literature

(E)-1-{4-[Bis(4-meth-oxy-phen-yl)meth-yl]piperazin-1-yl}-3-(4-methyl-phen-yl)prop-2-en-1-one.

Project description:In the title mol-ecule, C(29)H(32)N(2)O(3), the piperazine ring has a chair conformation. The amide N atom is almost planar (bond angle sum = 359.5°), whereas the other N atom is clearly pyramidal (bond angle sum = 330.4°). The dihedral angle between the meth-oxy-benzene rings is 81.29?(16)°. In the crystal, mol-ecules are linked by C-H?O hydrogen bonds.

| S-EPMC3201336 | biostudies-literature

(E)-1-{4-[Bis(4-meth-oxy-phen-yl)meth-yl]piperazin-1-yl}-3-(4-fluoro-phen-yl)prop-2-en-1-one.

Project description:In the title compound, C(28)H(29)FN(2)O(3), the conformation about the ethene bond is E. The piperazine ring adopts a chair conformation. In the crystal, mol-ecules are linked by inter-molecular C-H⋯O hydrogen bonds.

| S-EPMC3051918 | biostudies-literature

(E)-1-{4-[Bis(4-fluoro-phen-yl)meth-yl]piperazin-1-yl}-3-(4-eth-oxy-phen-yl)prop-2-en-1-one.

Project description:In the title mol-ecule, C(28)H(28)F(2)N(2)O(2), the ethene bond exhibits an E conformation and the piperazine ring adopts a chair conformation. The amide-N atom of the piperazine ring is almost planar (bond-angle sum = 358.8°) whereas the other N atom is clearly pyramidal (bond-angle sum = 330.5°). The dihedral angle between the fluoro-benzene rings is 76.36 (17)°. In the crystal, inversion dimers linked by pairs of C-H⋯O hydrogen bonds generate R(2) (2)(22) loops.

| S-EPMC3238988 | biostudies-literature

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

Tweets

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data